1260044

Prinston Pharmaceutical Inc. — FEI 3009298353

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Somerset, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)